Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Holmusk Announces Closing of Strategic Investment from Healthcare and Life Science Industry Leaders
Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]
Holmusk Signs Agreements with UTHealth and The Harris Center
Holmusk, a leading global data science and health technology company building the world’s largest Real-World […]
Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
Otsuka Pharmaceutical Development & Commercialization, Inc. (“Otsuka”), announces today that it has entered a three-year […]
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK
Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more